Time 18:00 – 19:30		Date Sept 17th	Poster session 2 In addition to orals presented today the following poster only presentations are scheduled for this session
Old Abstract #	New Abstract #	Presenter	Title Presentation
1	77	David Godler	IMPROVED METHODOLOGY FOR ASSESSMENT OF mRNA LEVELS IN BLOOD OF PATIENTS WITH FMR1 RELATED DISORDERS
5	78	Charles Lourenço	GENETIC SCREENING TO DETERMINE AN ETIOLOGICAL DIAGNOSIS IN PATIENTS WITH MENTAL RETARDATION IN A SOUTHEAST REGION OF BRAZIL
21	79	Charles Schwartz	TWO-PERCENT OF PATIENTS SUSPECTED OF HAVING ANGELMAN SYNDROME HAVE TCF4 MUTATIONS
22	80	Ilari Meloni	MUTATIONS IN THE FOXG1 GENE CAUSE THE CONGENITAL VARIANT OF RETT SYNDROME
23	81	Pietro Chiurazzi	A SPLICING MUTATION IN THE OPHN1 GENE CAUSES MENTAL RETARDATION AND CEREBELLAR HYPOPLASIA IN A THREE GENERATION ITALIAN FAMILY
25	82	Ted Brown	Selective Identification of Lymphoblastoid Extracts from Fragile-X or Control Subjects utilizing Monoclonal Antibodies to FMR1 (FMRP)
30	83	Karen Usdin	Different sides of the same coin? Repeat expansion and chromosome fragility in Fragile X syndrome
38	84	Montserrat Mila	NO EVIDENCE FOR SKEWED X-CHROMOSOME INACTIVATION IN FRAGILE X SYNDROME PREMUTATION CARRIERS
39	85	Larissa Fontes	DISTRIBUTION OF FMRP TO GRANULES IN HUMAN GRANULOSA CELLS UPON STRESS
40	86	Stephanie Sherman	Co-occurring diagnoses among FMR1 premutation allele carriers
45	87	Marketa Havlovicova	FMR1 Gene Expansion, Large Deletion of Xp and Skewed X-inactivation in a Girl with Mental Retardation and Autism
65	88	Andrea Schneider	Prepulse Inhibition in Patients with FXTAS
105	89	Ana Krepischi	2q24.2 microdeletions encompassing the SLC4A10 gene are associated with idiopathic epilepsy and mental impairment
101	90	Justin Cowan	ESTABLISHING SYSTEMS FOR EVALUATING TREATMENT EFFECTS ON THE NEURONAL AND BEHAVIOURAL PHENOTYPE OF FRAGILE X SYNDROME